Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Oncoimmunology
|
May 4, 2016
Vemurafenib and ipilimumab: A promising combination? Results of a case series
Jessica C Hassel, Sophia B Lee, Frank Meiss, et al.
Acta Dermato-Venereologica
|
June 20, 2023
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
Laura Trefzer, Maria E Hess, Lena Scholten, et al.
Acta Dermato-Venereologica
|
November 9, 2013
Iatrogenic vitamin D deficiency in a patient with Gorlin syndrome: the conundrum of photoprotection
Sabrina Gentzsch, Johannes S Kern, Stefan Loeckermann, et al.
Journal of Translational Medicine
|
December 12, 2022
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity
Zhen Zhang, David Rafei-Shamsabadi, Saskia Lehr, et al.
The Journal of Investigative Dermatology
|
October 22, 2017
Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival
Felicia Rubel, Johannes S Kern, Kristin Technau-Hafsi, et al.
Pediatric Blood & Cancer
|
December 6, 2021
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma
Klara-Maria Hanft, Ebrahem Hamed, Max Kaiser, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
November 22, 2017
Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas
Melanie C Föll, Matthias Fahrner, Christine Gretzmeier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Orphanet Journal of Rare Diseases
|
December 5, 2019
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
Andrea Diociaiuti, Holger Steinke, Alexander Nyström, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers
Markus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Oncoimmunology
|
May 4, 2016
Vemurafenib and ipilimumab: A promising combination? Results of a case series
Jessica C Hassel, Sophia B Lee, Frank Meiss, et al.
Acta Dermato-Venereologica
|
June 20, 2023
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
Laura Trefzer, Maria E Hess, Lena Scholten, et al.
Acta Dermato-Venereologica
|
November 9, 2013
Iatrogenic vitamin D deficiency in a patient with Gorlin syndrome: the conundrum of photoprotection
Sabrina Gentzsch, Johannes S Kern, Stefan Loeckermann, et al.
Journal of Translational Medicine
|
December 12, 2022
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity
Zhen Zhang, David Rafei-Shamsabadi, Saskia Lehr, et al.
The Journal of Investigative Dermatology
|
October 22, 2017
Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival
Felicia Rubel, Johannes S Kern, Kristin Technau-Hafsi, et al.
Pediatric Blood & Cancer
|
December 6, 2021
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma
Klara-Maria Hanft, Ebrahem Hamed, Max Kaiser, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
November 22, 2017
Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas
Melanie C Föll, Matthias Fahrner, Christine Gretzmeier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Orphanet Journal of Rare Diseases
|
December 5, 2019
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
Andrea Diociaiuti, Holger Steinke, Alexander Nyström, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers
Markus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Page
of 11